NFKB1 and breast carcinoma: <b>Conclusions</b>: The novel combination of withaferin A and sodium butyrate have markedly reduced the progression of breast cancer-derived cell lines for cell viability, epigenetic <i>DNMT</i> gene expression, as well as inhibiting <i>NFκB1</i> signaling on the gene expression level.